Inpsyde Health Ltd 12592185 false 2024-06-01 2025-05-31 2025-05-31 The principal activity of the company is Hospital activities Digita Accounts Production Advanced 6.30.9574.0 true true 12592185 2024-06-01 2025-05-31 12592185 2025-05-31 12592185 core:CurrentFinancialInstruments 2025-05-31 12592185 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 12592185 core:FurnitureFittingsToolsEquipment 2025-05-31 12592185 bus:SmallEntities 2024-06-01 2025-05-31 12592185 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 12592185 bus:FilletedAccounts 2024-06-01 2025-05-31 12592185 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 12592185 bus:RegisteredOffice 2024-06-01 2025-05-31 12592185 bus:Director1 2024-06-01 2025-05-31 12592185 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 12592185 bus:Agent1 2024-06-01 2025-05-31 12592185 core:OfficeEquipment 2024-06-01 2025-05-31 12592185 countries:EnglandWales 2024-06-01 2025-05-31 12592185 2024-05-31 12592185 core:FurnitureFittingsToolsEquipment 2024-05-31 12592185 2023-06-01 2024-05-31 12592185 2024-05-31 12592185 core:CurrentFinancialInstruments 2024-05-31 12592185 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 12592185 core:FurnitureFittingsToolsEquipment 2024-05-31 iso4217:GBP xbrli:pure

Registration number: 12592185

Inpsyde Health Ltd
Unaudited Filleted Financial Statements
for the Year Ended 31 May 2025

Inpsyde Health Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 7

Inpsyde Health Ltd

Company Information

Director | Dr P Tomlins

Registered office | 320 Garratt Lane London SW18 4EJ

Accountants | Franklin, Chartered Accountants 320 Garratt Lane London SW18 4EJ

Inpsyde Health Ltd

(Registration number: 12592185)
Balance Sheet as at 31 May 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 2,386 | 5,401
Current assets |  |  |
Debtors | 5 | 16,701 | -
Cash at bank and in hand |  | 11,417 | 27,657
|  | 28,118 | 27,657
Creditors: Amounts falling due within one year | 6 | (32,627) | (21,449)
Net current (liabilities)/assets |  | (4,509) | 6,208
Net (liabilities)/assets |  | (2,123) | 11,609
Capital and reserves |  |  |
Called up share capital | 7 | 1 | 1
Retained earnings |  | (2,124) | 11,608
Shareholders' (deficit)/funds |  | (2,123) | 11,609

For the financial year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 16 January 2026

......................................... Dr P Tomlins Director

Inpsyde Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
320 Garratt Lane
London
SW18 4EJ

These financial statements were authorised for issue by the director on 16 January 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Inpsyde Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office Equipment | 3 years straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Inpsyde Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Financial instruments

Classification
The Company has chosen to adopt sections 11 and 12 of FRS 102 in respect of financial instruments.
Recognition and measurement
Financial instruments are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.
Such assets are subsequently carried at amortised cost using the effective interest method.
At the end of each reporting period, financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate.
Impairment
Financial instruments are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.
Such assets are subsequently carried at amortised cost using the effective interest method.
At the end of each reporting period, financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

Inpsyde Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

4 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 June 2024 | 2,386 | 2,386
At 31 May 2025 | 2,386 | 2,386
Depreciation
Carrying amount
At 31 May 2025 | 2,386 | 2,386
At 31 May 2024 | 5,401 | 5,401

5 | Debtors

Current | 2025 £ | 2024 £
Other debtors | 16,701 | -
| 16,701 | -

6 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Taxation and social security | 31,187 | 19,758
Other creditors | 1,440 | 1,691
| 32,627 | 21,449

Inpsyde Health Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

7 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary of £0.01 each | 100 | 1 | 100 | 1